Synulin AI: Synchronized Insulin Pen with Integrated Al Agent Control
Reference: CPP2024-011898
Duration 2024-2027
Founded by: AEI
Amount: 875.000,00 €
In collaboration with Insulcloud
Filter by completion year
ONGOING PROJECTS
Personal digital twin: A virtual human twin for therapy adjustment in people with diabetes
Reference: 2024 PROD 00051
Duration 2024-2026
Founded by: AGAUR
Amount: 145.500€
Principal Investigator: Omer Mujahid
Bidirectional Brain-Body Interactions and Refinement of Multidimensional Electrical Neuromodulation for Enhanced Living (IRENE)
Reference: PID2023-149837OB-I00
Duration 2024 – 2027
Founded by: MICIU, AEI & FEDER
Amount: 138.250 €
In collaboration with IDIBGI, FUNDACIÓ DE RECERCA CLÍNIC BARCELONA & UNIVERSITY OF CAMBRIDGE
Principal Investigator: Iván Contreras
DEXCOM Chair in the Application of Artificial Intelligence in Diabetes and Associated Pathologies
Reference: TSI-100932-2023-1
Duration 2023-2026
Founded by: the Ministry of Digital Transformation and Civil Service
Amount: 899.999,78€
Principal Investigator: Josep Vehí
Glucose control in women versus men: towards sex-specific insulin therapies in type 1 diabetes (DIABETEXX)
Reference: PID2022-137723OB-C22
Duration 2023 – 2026
Founded by: MICINN & AEI
Amount: 421.250 €
In collaboration with Universitat Politècnica de València
Principal Investigator: Josep Vehí
Preterm Brain-Oxygenation and Metabolic EU-Sensing: Feed the Brain (PROMETEUS)
Reference: 101099093
Duration 2023 – 2027
Founded by: European Commission
Amount: 3.721.656,25€
In collaboration with Universita degli studio di Padova,Qulab Medical Ltd, Politecnico de Milano, Pionirs SRL, University Collage of London, Fundacio Institut de Ciencies fotoniques, Dace Srl, Universite Grenoble Alpes, Institut National de la Sante et de la Recherche Medicale and University College Cork.
Principal Investigator: Josep Vehí
FINISHED PROJECTS
Towards a new generation of digital diabetes solutions: Artificial pancreas for patients with continuous monitoring devices and smart insulin pens
Reference: CPP2021-008659
Duration 2022 – 2025
Founded by: MCINN
Amount: 656.441,06€
In collaboration with Social Diabetes
Principal Investigator: Josep Vehí
Universal Concentrator Assisted by Online Recommendation Technology
Reference: CPP2021-009139
Duration 2022 - 2025
Founded by: MCINN
Amount: 1.568.129,80€
In collaboration with Insulcloud S.L.
Principal Investigator: Josep Vehí
Modelling and Control of Non-invasive Vagus Nerve Stimulation for autoimmune diseases (VaNeSA)
Reference: PID2020-117171RA-I00
Duration 2021-2024
Founded by: MICINN
Amount: 117.370 €
Principal Investigator: Iván Contreras
Tailor – Patient-TAILORed solutions for blood glucose control in T1D
Reference: PID2019-107722RB-C22
Duration 2020-2023
Founded by: MCIU/AEI
Amount: 211.503€
In collaboration with Universitat Politècnica de València, Fundació Privada Clínic per a la Recerca Biomèdica, Fundació per a la Recerca i la Docència Sant Joan De Deu (FSJD), Imperial College of London
Principal Investigator: Josep Vehí